MARTHA LANGHORNE: Open Payments
NPI 1972563005 · BINGHAMTON, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,266 in 33 payments from 6 companies in 2025. Trend: 2023 $1,266 · 2024 $1,615 · 2025 $1,266
Food & beverage: $1,266
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $474 |
| ABBVIE INC. | 6 | $304 |
| Madrigal Pharmaceuticals | 5 | $173 |
| Janssen Biotech, Inc. | 16 | $172 |
| Incyte Corporation | 1 | $125 |
| Phathom Pharmaceuticals, Inc. | 1 | $17 |
Products named: REZDIFFRA, TREMFYA, Monjuvi, DATROWAY, SKYRIZI, ELAHERE, VENCLEXTA, RINVOQ.
Industry payments across NY — which companies pay providers there.
